Managing Myeloma
- 2011-03-29 - Dr. Elaine Schattner: Geraldine Ferraro and Our Progress in Treating Myeloma--HuffPost Health
- 2011-03-28 - Onyx Pharmaceuticals Announces Plans to Amend Phase 3 FOCUS Study for European Registration--PRNewswire
- 2011-03-25 - Genome Map of Multiple Myeloma Offers Clues to Its Cause -- US NEWS & World Report
- 2011-03-25 - Beacon BreakingNews – European Multiple Myeloma Researchers Issue Statement on Lenalidomide and Secondary Cancers
- 2011-03-23 - BREAKING NEWS- Europe opens up clinical trials database
- 2011-03-23 - Multiple Myeloma, A Review by Drs. Palumbo and Anderson- NEJM
- 2011-03-23 - Patients flock to Facebook for health care needs--Dayton Business Journal
- 2011-03-21 - The type III TGF-{beta} receptor inhibits proliferation, migration and adhesion in human myeloma cells.-- Mol Cell Bio
- 2011-03-20 - Treatment options for relapsed and refractory multiple myeloma.--Clin Cancer Res.
- 2011-03-20 - Advances in the biology and treatment of bone disease in multiple myeloma.--Clin Cancer Res.
- 2011-03-20 - NCCN Tweaks 2011 Multiple Myeloma Guidelines--Medscape
- 2011-03-19 - The MMRF and John Theurer Cancer Center to host patient symposium
- 2011-03-16 - Cop with cancer fears city will appeal workers comp case -- Easy Reader News
- 2011-03-15 - Spencer was a hit--Trib Today.com
- 2011-03-15 - Innovation Thrives At ASH 2010--Medical News Today